February 1, 2023Open Access
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis
Key Points
Key points are not available for this paper at this time.
Abstract
NCT02675426, NCT02706951, NCT02706847, NCT02629159, NCT02706873, NCT03086343, NCT03104374, NCT03104400, NCT03178487, NCT03569293, NCT03568318 and NCT03607422.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Cite this study
Burmester et al. (Wed,) studied this question.
synapsesocial.com/papers/69dad2a50d8d6ef495a3c4c5 — DOI: https://doi.org/10.1136/rmdopen-2022-002735
Authors
Gerd R Burmester
University of Siena
S
Stanley Cohen
Texas Health Dallas
K
Kevin Winthrop
University of North Carolina at Chapel Hill
Journals
RMD Open
SHILAP Revista de lepidopterología
Actions
Institutions
Icahn School of Medicine at Mount Sinai
Oregon Health & Science University
Charité - Universitätsmedizin Berlin
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...